세계의 비호르몬 피임 시장 보고서(2025년)

Non-Hormonal Contraceptives Global Market Report 2025

US $ 4,490 ￦ 6,394,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,242,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 12,090,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

비호르몬 피임 시장 규모는 향후 몇 년 동안 강력한 성장이 예상됩니다. 2029년에는 CAGR 7.1%로 334억 8,000만 달러에 달할 전망입니다. 예측 기간 동안 예상되는 성장의 원동력은 호르몬을 사용하지 않는 피임법에 대한 수요 증가, 호르몬 피임약과 관련된 부작용에 대한 인식 증가, 자연적이고 화학적이지 않은 피임법에 대한 선호도 증가, 성병 유병률 증가, 생식 건강에 대한 여성들의 인식 증가입니다. 증가입니다. 이 기간 동안 주요 동향으로는 비호르몬 피임기구를 위한 생체재료의 발전, 배리어 피임기구 설계의 기술 혁신, 가임력 인식 기술에 스마트 추적 기능의 통합, 무약물 피임젤 및 피임 필름의 발전, 피임기구를 위한 기술을 이용한 자가 관리 도구의 개발 등을 들 수 있습니다. 도구의 개발 등을 들 수 있습니다.

성병 증가는 향후 비호르몬 피임 시장의 성장을 견인할 것으로 예측됩니다. 성병(STD)은 주로 성접촉을 통해 감염되는 감염병으로 세균, 바이러스, 기생충에 의해 발생합니다. 성병 증가는 콘돔 사용률의 감소로 인해 무방비 상태의 성행위로 인한 감염 위험이 높아졌기 때문입니다. 남성용 콘돔이나 여성용 콘돔과 같은 비호르몬 피임은 성행위 중 체액 교환을 막는 물리적 장벽 역할을 하여 성병 감염을 줄이는 데 도움이 됩니다. 예를 들어, 2025년 4월 미국 미네소타주 보건국(MDH)은 35-39세 남성의 HIV 감염자 비율이 2023년 10%에서 2024년 17%로 증가했다고 보고했습니다. 이처럼 성병의 확산이 비호르몬 피임 시장 확대에 기여하고 있습니다.

비호르몬 피임 시장의 기업들은 삽입을 용이하게 하고, 사용자의 편의성을 높이고, 임상 효율성을 향상시키기 위해 프리로딩 자궁 내 피임기구(IUD) 전달 시스템과 같은 혁신적인 전달 시스템에 초점을 맞추었습니다. 프리로딩 IUD 전달 시스템은 삽입 과정을 간소화하고, 설정 시간을 단축하며, 오염 및 취급 실수의 위험을 줄이기 위해 장치와 삽입기를 하나의 즉시 사용 가능한 장치로 결합하여 설계되었습니다. 예를 들어, 2024년 9월 미국의 의료기기 및 불임 치료 기업 쿠퍼 서지컬(Cooper Surgical)은 비호르몬성 IUD 삽입 시 삽입 효율과 환자의 편안함을 향상시키기 위해 파라가드 싱글 핸드 인서트(Paragard Single Hand Inserter)를 출시하였습니다. 이 장치는 정자가 난자와 수정되는 것을 방지하여 99% 이상 효과적이며, 최대 10년간 장기 피임이 가능합니다. 호르몬을 사용하지 않고, 즉각적이고 가역적인 피임이 가능하며, 삽입 후 유지 보수가 적습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 코로나재난과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계 성장 분석과 전략 분석 프레임워크

• 세계의 비호르몬 피임 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
• 최종 이용 산업 분석
• 세계의 비호르몬 피임 시장 : 성장률 분석
• 세계의 비호르몬 피임시장 실적 : 규모와 성장, 2019-2024년
• 세계의 비호르몬 피임시장 예측 : 규모와 성장, 2024-2029년, 2034년
• 세계의 비호르몬 피임 : 전체 시장(TAM)

제6장 시장 세분화

• 세계의 비호르몬 피임 시장 : 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 디바이스
• 멸균
• 기타
• 세계의 비호르몬 피임 시장 : 작용기전별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 길항제
• 작용제
• 억제제
• 조절인자
• 세계의 비호르몬 피임 시장 : 투여 경로별
• 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 근육내
• 질내
• 정맥내
• 경구
• 피하
• 국소
• 경피
• 기타
• 세계의 비호르몬 피임 시장 : 치료 목적별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 질병 치료
• 증상 관리
• 세계의 비호르몬 피임 시장 : 대상 적응증별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 세균성 질염
• 피임
• 자궁내막증
• 폐경 후 골다공증
• 자궁근종
• 질염
• 기타
• 세계의 비호르몬 피임 시장 : 디바이스별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 수술 기구
• 결찰 클립
• 난관 고리(Tubal Rings)
• 세계의 비호르몬 피임 시장 : 멸균별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 영구 멸균
• 가역적 멸균
• 기계 멸균 장비
• 세계의 비호르몬 피임 시장 : 기타별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 비외과적 배리어 디바이스
• 이식형 플러그
• 자궁내 영구 피임기구

제7장 지역별/국가별 분석

• 세계의 비호르몬 피임 시장 : 지역별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 세계의 비호르몬 피임 시장 : 국가별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

• 비호르몬 피임 시장 : 경쟁 구도
• 비호르몬 피임 시장 : 기업 개요
  • Bayer AG.
  • Church & Dwight Co.
  • Mankind Pharma Limited
  • Okamoto Industries
  • CooperSurgical Inc.

제31장 기타 주요 기업 및 혁신 기업

• PSI India Pvt Ltd.
• Karex Berhad
• Natural Cycles Nordic AB
• Fuji Latex Co. Ltd.
• PREGNA INTERNATIONAL LTD.
• Cupid Limited
• Veru Inc.
• Evofem Biosciences Inc.
• Dare Bioscience Inc.
• Global Protection Corp.
• SMB Corporation of India
• HLL Lifecare Limited
• YourChoice Therapeutics Inc.
• Cirqle Biomedical Contraception ApS
• Eppin Pharma Inc.

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장 잠재력이 높은 국가, 전략

• 비호르몬 피임시장, 2029년 : 새로운 기회를 제공하는 국가
• 비호르몬 피임시장, 2029년 : 새로운 기회를 제공하는 부문
• 비호르몬 피임시장, 2029년 : 성장 전략
  • 시장 동향에 의한 전략
  • 경쟁 전략

제36장 부록

LSH

영문 목차

영문목차

Non-hormonal contraceptives are methods used to prevent pregnancy without involving hormones that alter a woman's reproductive system. These contraceptives work by using physical barriers, chemical agents, or natural tracking techniques that do not interfere with the body's hormonal balance.

The primary categories of non-hormonal contraceptives include devices, sterilization, and others. Devices are physical tools or instruments designed to carry out specific functions, often applied in medical, industrial, or consumer settings. Their mechanisms may involve acting as antagonists, agonists, inhibitors, or modulators. These products can be administered via various routes such as intramuscular, intravaginal, intravenous, oral, subcutaneous, topical, transdermal, and more. Their therapeutic purposes cover both disease treatment and symptom relief. The target conditions for these contraceptives include bacterial vaginosis, contraception, endometriosis, postmenopausal osteoporosis, uterine fibroids, vaginitis, among others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The non-hormonal contraceptives market research report is one of a series of new reports from The Business Research Company that provides non-hormonal contraceptives market statistics, including non-hormonal contraceptives global market size, regional shares, competitors with non-hormonal contraceptives market share, detailed non-hormonal contraceptives market segments, market trends and opportunities, and any further data you may need to thrive in the non-hormonal contraceptives industry. The non-hormonal contraceptives market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The non-hormonal contraceptives market size has grown strongly in recent years. It will grow from $23.73 billion in 2024 to $25.47 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth during the historic period can be credited to increasing support for women's health initiatives, the expanding availability of over-the-counter non-hormonal contraceptive options, a heightened focus on developing male contraceptive products, rising demand for fertility-awareness-based contraceptive methods, and a growing number of product approvals and launches within the non-hormonal contraceptive market.

The non-hormonal contraceptives market size is expected to see strong growth in the next few years. It will grow to $33.48 billion in 2029 at a compound annual growth rate (CAGR) of 7.1%. The growth expected in the forecast period is driven by rising demand for hormone-free birth control options, increased awareness of side effects linked to hormonal contraceptives, a growing preference for natural and chemical-free methods, the increasing prevalence of sexually transmitted infections, and heightened health consciousness among women about reproductive health. Key trends during this time include advancements in biomaterials for non-hormonal contraceptive devices, technological innovations in barrier contraceptive designs, the incorporation of smart tracking features with fertility-awareness techniques, progress in drug-free contraceptive gels and films, and the development of technology-enabled self-administration tools for contraceptive devices.

The rising prevalence of sexually transmitted diseases is expected to drive growth in the non-hormonal contraceptives market in the future. Sexually transmitted diseases (STDs) are infections primarily spread through sexual contact and caused by bacteria, viruses, or parasites. The increase in STDs is largely due to a decrease in condom use, which raises the risk of infection during unprotected sex. Non-hormonal contraceptives, such as male and female condoms, act as a physical barrier that prevents the exchange of bodily fluids during sexual activity, helping to reduce the transmission of STDs. For example, in April 2025, the Minnesota Department of Health (MDH), a US state health agency, reported that the proportion of HIV cases among males aged 35 to 39 rose from 10% in 2023 to 17% in 2024. Thus, the growing prevalence of sexually transmitted diseases is contributing to the expansion of the non-hormonal contraceptives market.

Companies in the non-hormonal contraceptives market are focusing on innovative delivery systems such as preloaded intrauterine device (IUD) delivery systems to make insertion easier, increase user convenience, and improve clinical efficiency. A preloaded IUD delivery system combines the device and its inserter into a single, ready-to-use unit designed to simplify the insertion process, reduce setup time, and lower the risk of contamination or handling errors. For instance, in September 2024, CooperSurgical Inc., a US-based medical device and fertility company, launched the Paragard Single-Handed Inserter, which aims to improve insertion efficiency and patient comfort during non-hormonal IUD placement. The device provides over 99% effective, long-term birth control for up to 10 years by preventing sperm from fertilizing an egg. It offers immediate, reversible contraception without hormones and requires low maintenance after insertion.

In July 2022, Organon International, a US pharmaceutical company, partnered with Cirqle Biomedical Contraception ApS to develop and commercialize an innovative, non-hormonal, on-demand contraceptive. This collaboration aims to expand contraceptive options and address unmet needs in women's health. Cirqle Biomedical Contraception ApS is a Denmark-based life sciences company focused on creating non-hormonal contraceptive solutions for women.

Major players in the non-hormonal contraceptives market are Bayer AG., Church & Dwight Co., Mankind Pharma Limited, Okamoto Industries, CooperSurgical Inc., PSI India Pvt Ltd., Karex Berhad, Natural Cycles Nordic AB, Fuji Latex Co. Ltd., PREGNA INTERNATIONAL LTD., Cupid Limited, Veru Inc., Evofem Biosciences Inc., Dare Bioscience Inc., Global Protection Corp., SMB Corporation of India, HLL Lifecare Limited, YourChoice Therapeutics Inc., Cirqle Biomedical Contraception ApS, Eppin Pharma Inc., Contraline Inc., and Linepharma International Ltd.

North America was the largest region in the non-hormonal contraceptives market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in non-hormonal contraceptives report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the non-hormonal contraceptives market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The non-hormonal contraceptives market consists of sales of male condoms, copper intrauterine devices (IUDs), diaphragms, cervical caps, and spermicides. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Non-Hormonal Contraceptives Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on non-hormonal contraceptives market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for non-hormonal contraceptives ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The non-hormonal contraceptives market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Devices; Sterilization; Other Product Types
• 2) By Mechanism Of Action: Antagonist; Agonist; Inhibitor; Modulator
• 3) By Route of Administration: Intramuscular; Intravaginal; Intravenous; Oral; Subcutaneous; Topical; Transdermal; Other Route Of Administrations
• 4) By Purpose Of Therapy: Treatment Of Disease; Management Of Symptoms
• 5) By Target Indication: Bacterial Vaginosis; Contraception; Endometriosis; Postmenopausal Osteoporosis; Uterine Fibroids; Vaginitis; Other Target Indications
• Subsegments:
• 1) By Devices: Surgical Instruments; Ligation Clips; Tubal Rings
• 2) By Sterilization: Permanent Sterilization; Reversible Sterilization; Mechanical Sterilization Devices
• 3) By Other Product Types: Non-Surgical Barrier Devices; Implantable Plugs; Intrauterine Permanent Devices
• Companies Mentioned: Bayer AG.; Church & Dwight Co.; Mankind Pharma Limited; Okamoto Industries; CooperSurgical Inc.; PSI India Pvt Ltd.; Karex Berhad; Natural Cycles Nordic AB; Fuji Latex Co. Ltd.; PREGNA INTERNATIONAL LTD.; Cupid Limited; Veru Inc.; Evofem Biosciences Inc.; Dare Bioscience Inc.; Global Protection Corp.; SMB Corporation of India; HLL Lifecare Limited; YourChoice Therapeutics Inc.; Cirqle Biomedical Contraception ApS; Eppin Pharma Inc.; Contraline Inc.; Linepharma International Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Non-Hormonal Contraceptives Market Characteristics

3. Non-Hormonal Contraceptives Market Trends And Strategies

4. Non-Hormonal Contraceptives Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Non-Hormonal Contraceptives Growth Analysis And Strategic Analysis Framework

• 5.1. Global Non-Hormonal Contraceptives PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Non-Hormonal Contraceptives Market Growth Rate Analysis
• 5.4. Global Non-Hormonal Contraceptives Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Non-Hormonal Contraceptives Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Non-Hormonal Contraceptives Total Addressable Market (TAM)

6. Non-Hormonal Contraceptives Market Segmentation

• 6.1. Global Non-Hormonal Contraceptives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Devices
• Sterilization
• Other Product Types
• 6.2. Global Non-Hormonal Contraceptives Market, Segmentation By Mechanism of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antagonist
• Agonist
• Inhibitor
• Modulator
• 6.3. Global Non-Hormonal Contraceptives Market, Segmentation By Route of Administration
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Intramuscular
• Intravaginal
• Intravenous
• Oral
• Subcutaneous
• Topical
• Transdermal
• Other Route of Administrations
• 6.4. Global Non-Hormonal Contraceptives Market, Segmentation By Purpose of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Treatment Of Disease
• Management Of Symptoms
• 6.5. Global Non-Hormonal Contraceptives Market, Segmentation By Target Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bacterial Vaginosis
• Contraception
• Endometriosis
• Postmenopausal Osteoporosis
• Uterine Fibroids
• Vaginitis
• Other Target Indications
• 6.6. Global Non-Hormonal Contraceptives Market, Sub-Segmentation Of Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Surgical Instruments
• Ligation Clips
• Tubal Rings
• 6.7. Global Non-Hormonal Contraceptives Market, Sub-Segmentation Of Sterilization, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Permanent Sterilization
• Reversible Sterilization
• Mechanical Sterilization Devices
• 6.8. Global Non-Hormonal Contraceptives Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Non-Surgical Barrier Devices
• Implantable Plugs
• Intrauterine Permanent Devices

7. Non-Hormonal Contraceptives Market Regional And Country Analysis

• 7.1. Global Non-Hormonal Contraceptives Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Non-Hormonal Contraceptives Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Non-Hormonal Contraceptives Market

• 8.1. Asia-Pacific Non-Hormonal Contraceptives Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Non-Hormonal Contraceptives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Non-Hormonal Contraceptives Market, Segmentation By Mechanism of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Non-Hormonal Contraceptives Market, Segmentation By Route of Administration
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Non-Hormonal Contraceptives Market

• 9.1. China Non-Hormonal Contraceptives Market Overview
• 9.2. China Non-Hormonal Contraceptives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Non-Hormonal Contraceptives Market, Segmentation By Mechanism of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Non-Hormonal Contraceptives Market, Segmentation By Route of Administration
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Non-Hormonal Contraceptives Market

• 10.1. India Non-Hormonal Contraceptives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Non-Hormonal Contraceptives Market, Segmentation By Mechanism of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Non-Hormonal Contraceptives Market, Segmentation By Route of Administration
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Non-Hormonal Contraceptives Market

• 11.1. Japan Non-Hormonal Contraceptives Market Overview
• 11.2. Japan Non-Hormonal Contraceptives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Non-Hormonal Contraceptives Market, Segmentation By Mechanism of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Non-Hormonal Contraceptives Market, Segmentation By Route of Administration
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Non-Hormonal Contraceptives Market

• 12.1. Australia Non-Hormonal Contraceptives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Non-Hormonal Contraceptives Market, Segmentation By Mechanism of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Non-Hormonal Contraceptives Market, Segmentation By Route of Administration
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Non-Hormonal Contraceptives Market

• 13.1. Indonesia Non-Hormonal Contraceptives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Non-Hormonal Contraceptives Market, Segmentation By Mechanism of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Non-Hormonal Contraceptives Market, Segmentation By Route of Administration
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Non-Hormonal Contraceptives Market

• 14.1. South Korea Non-Hormonal Contraceptives Market Overview
• 14.2. South Korea Non-Hormonal Contraceptives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Non-Hormonal Contraceptives Market, Segmentation By Mechanism of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Non-Hormonal Contraceptives Market, Segmentation By Route of Administration
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Non-Hormonal Contraceptives Market

• 15.1. Western Europe Non-Hormonal Contraceptives Market Overview
• 15.2. Western Europe Non-Hormonal Contraceptives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Non-Hormonal Contraceptives Market, Segmentation By Mechanism of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Non-Hormonal Contraceptives Market, Segmentation By Route of Administration
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Non-Hormonal Contraceptives Market

• 16.1. UK Non-Hormonal Contraceptives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Non-Hormonal Contraceptives Market, Segmentation By Mechanism of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Non-Hormonal Contraceptives Market, Segmentation By Route of Administration
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Non-Hormonal Contraceptives Market

• 17.1. Germany Non-Hormonal Contraceptives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Non-Hormonal Contraceptives Market, Segmentation By Mechanism of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Non-Hormonal Contraceptives Market, Segmentation By Route of Administration
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Non-Hormonal Contraceptives Market

• 18.1. France Non-Hormonal Contraceptives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Non-Hormonal Contraceptives Market, Segmentation By Mechanism of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Non-Hormonal Contraceptives Market, Segmentation By Route of Administration
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Non-Hormonal Contraceptives Market

• 19.1. Italy Non-Hormonal Contraceptives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Non-Hormonal Contraceptives Market, Segmentation By Mechanism of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Non-Hormonal Contraceptives Market, Segmentation By Route of Administration
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Non-Hormonal Contraceptives Market

• 20.1. Spain Non-Hormonal Contraceptives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Non-Hormonal Contraceptives Market, Segmentation By Mechanism of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Non-Hormonal Contraceptives Market, Segmentation By Route of Administration
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Non-Hormonal Contraceptives Market

• 21.1. Eastern Europe Non-Hormonal Contraceptives Market Overview
• 21.2. Eastern Europe Non-Hormonal Contraceptives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Non-Hormonal Contraceptives Market, Segmentation By Mechanism of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Non-Hormonal Contraceptives Market, Segmentation By Route of Administration
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Non-Hormonal Contraceptives Market

• 22.1. Russia Non-Hormonal Contraceptives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Non-Hormonal Contraceptives Market, Segmentation By Mechanism of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Non-Hormonal Contraceptives Market, Segmentation By Route of Administration
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Non-Hormonal Contraceptives Market

• 23.1. North America Non-Hormonal Contraceptives Market Overview
• 23.2. North America Non-Hormonal Contraceptives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Non-Hormonal Contraceptives Market, Segmentation By Mechanism of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Non-Hormonal Contraceptives Market, Segmentation By Route of Administration
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Non-Hormonal Contraceptives Market

• 24.1. USA Non-Hormonal Contraceptives Market Overview
• 24.2. USA Non-Hormonal Contraceptives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Non-Hormonal Contraceptives Market, Segmentation By Mechanism of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Non-Hormonal Contraceptives Market, Segmentation By Route of Administration
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Non-Hormonal Contraceptives Market

• 25.1. Canada Non-Hormonal Contraceptives Market Overview
• 25.2. Canada Non-Hormonal Contraceptives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Non-Hormonal Contraceptives Market, Segmentation By Mechanism of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Non-Hormonal Contraceptives Market, Segmentation By Route of Administration
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Non-Hormonal Contraceptives Market

• 26.1. South America Non-Hormonal Contraceptives Market Overview
• 26.2. South America Non-Hormonal Contraceptives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Non-Hormonal Contraceptives Market, Segmentation By Mechanism of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Non-Hormonal Contraceptives Market, Segmentation By Route of Administration
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Non-Hormonal Contraceptives Market

• 27.1. Brazil Non-Hormonal Contraceptives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Non-Hormonal Contraceptives Market, Segmentation By Mechanism of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Non-Hormonal Contraceptives Market, Segmentation By Route of Administration
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Non-Hormonal Contraceptives Market

• 28.1. Middle East Non-Hormonal Contraceptives Market Overview
• 28.2. Middle East Non-Hormonal Contraceptives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Non-Hormonal Contraceptives Market, Segmentation By Mechanism of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Non-Hormonal Contraceptives Market, Segmentation By Route of Administration
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Non-Hormonal Contraceptives Market

• 29.1. Africa Non-Hormonal Contraceptives Market Overview
• 29.2. Africa Non-Hormonal Contraceptives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Non-Hormonal Contraceptives Market, Segmentation By Mechanism of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Non-Hormonal Contraceptives Market, Segmentation By Route of Administration
• , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Non-Hormonal Contraceptives Market Competitive Landscape And Company Profiles

• 30.1. Non-Hormonal Contraceptives Market Competitive Landscape
• 30.2. Non-Hormonal Contraceptives Market Company Profiles
  • 30.2.1. Bayer AG. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Church & Dwight Co. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Mankind Pharma Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Okamoto Industries Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. CooperSurgical Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Non-Hormonal Contraceptives Market Other Major And Innovative Companies

• 31.1. PSI India Pvt Ltd.
• 31.2. Karex Berhad
• 31.3. Natural Cycles Nordic AB
• 31.4. Fuji Latex Co. Ltd.
• 31.5. PREGNA INTERNATIONAL LTD.
• 31.6. Cupid Limited
• 31.7. Veru Inc.
• 31.8. Evofem Biosciences Inc.
• 31.9. Dare Bioscience Inc.
• 31.10. Global Protection Corp.
• 31.11. SMB Corporation of India
• 31.12. HLL Lifecare Limited
• 31.13. YourChoice Therapeutics Inc.
• 31.14. Cirqle Biomedical Contraception ApS
• 31.15. Eppin Pharma Inc.

32. Global Non-Hormonal Contraceptives Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Non-Hormonal Contraceptives Market

34. Recent Developments In The Non-Hormonal Contraceptives Market

35. Non-Hormonal Contraceptives Market High Potential Countries, Segments and Strategies

• 35.1 Non-Hormonal Contraceptives Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Non-Hormonal Contraceptives Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Non-Hormonal Contraceptives Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료